Structural basis for bitter taste receptor activation and its potential role in targeting diabetes

Authors

  • Ravinder Abrol Departments of Medicine and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Materials and Process Simulation Center, California Institute of Technology, Pasadena, CA, USA;
  • Jun Tan Materials and Process Simulation Center, California Institute of Technology, Pasadena, CA, USA; Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering College, Chongqing University, Chongqing, 400030, China;
  • Hongxiang Hui International Center for Metabolic Diseases, Southern Medical University, Guangzhou, China; Department of Medicine, University of California, Los Angeles, CA, USA
  • William A. Goddard III Materials and Process Simulation Center, California Institute of Technology, Pasadena, CA, USA;
  • Stephen J. Pandol Departments of Medicine and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA;Department of Medicine, University of California, Los Angeles, CA, USA

DOI:

https://doi.org/10.31989/ffhd.v5i3.176

Abstract

Background: Taste receptors are G protein-coupled receptors that, besides being present in the taste buds, have also been shown to be present in the gastrointestinal (GI) system, respiratory system, and brain, though their function at these locations is not well understood.

Objective: To understand the nutrient mediated release of gut peptides like GLP-1 from enteroendocrine L-cells of the GI system, we focused on a bitter taste receptor TAS2R38 (based on animal models) to investigate the structural basis of its potential role in the release of gut peptides. Methods: The atomic-level structure of bitter taste receptor TAS2R38 was predicted using GEnSeMBLE, a first-principle based GPCR structure prediction method. These structures were obtained for the dominant taster haplotype (PAV) as well as for the nontaster haplotype (AVI) of the receptor. The known ligands phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PTU) were docked to these structures to provide a structural basis for the taster and nontaster haplotypes.

Results: Docking of known ligands PTU and PTC to taster and nontaster haplotypes of the bitter taste receptor showed a backbone hydrogen bond to residue 262 in taster but not in nontaster haplotype, suggesting a potential mode of action of these molecules in the activation of the bitter taste receptor.

Conclusion: These results, combined with the ability of PTC to release gut peptides from in vitro models of the enteroendocrine L-cells, suggest a potential structural basis for TAS2R38 activation that can lead to the release of those peptides. This release has a therapeutic benefit for type 2 diabetes and implies a role for bitter tasting (but safe) natural compounds targeting TAS2R38 as potential drug candidates for curing type 2 diabetes.

Key words: TAS2R38, GLP-1 release, PYY release, CCK release, enteroendocrine L cell, GPCR, protein structure prediction, GEnSeMBLE

Downloads

Published

2015-03-18

Issue

Vol. 5 No. 3 (2015): March 2015

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.